Our Technologies
Our technologies enable the discovery and detection of unexplored full-length RNA sequences.
Precision targeting with full transcriptome context
Wobble Genomics’ ATLUS Targeting combines targeted enrichment with full-length RNA sequencing to deliver both sensitivity and biological context in a single assay.
Unlike traditional targeted approaches that focus only on predefined regions, ATLUS Targeting captures full-length transcripts while retaining transcriptome wide data. This enables precise detection of genes, isoforms, and fusion transcripts, as well as a broader understanding of gene expression and disease biology.
What it enables
High-Sensitivity Detection
Accurate identification of low-abundance, clinically relevant transcripts, including fusions and splice variants.
Full-Length Resolution
Precise characterisation of transcript structures, including isoforms and fusion breakpoints.
Contextual Insight
Integration of targeted findings with whole transcriptome data to reveal pathways, co-regulation, and additional biomarkers.
Why it matters
ATLUS Targeting bridges the gap between targeted detection and systems level insight.
It enables more confident diagnostics and more informed drug development by linking high-resolution RNA data with broader biological context.
Precision targeting with full transcriptome context
Wobble Genomics’ ATLUS Targeting combines targeted enrichment with full-length RNA sequencing to deliver both sensitivity and biological context in a single assay.
Unlike traditional targeted approaches that focus only on predefined regions, ATLUS Targeting captures full-length transcripts while retaining transcriptome wide data. This enables precise detection of genes, isoforms, and fusion transcripts, as well as a broader understanding of gene expression and disease biology.
What it enables
High-Sensitivity Detection
Accurate identification of low-abundance, clinically relevant transcripts, including fusions and splice variants.
Full-Length Resolution
Precise characterisation of transcript structures, including isoforms and fusion breakpoints.
Contextual Insight
Integration of targeted findings with whole transcriptome data to reveal pathways, co-regulation, and additional biomarkers.
Why it matters
ATLUS Targeting bridges the gap between targeted detection and systems level insight.
It enables more confident diagnostics and more informed drug development by linking high-resolution RNA data with broader biological context.
The RNA platform powering the next wave of precision medicine
Wobble Genomics’ Level-Up™ platform enables a deeper and more actionable understanding of RNA biology.
Designed for pharmaceutical and diagnostics partners, it captures full-length RNA transcripts to reveal critical variation missed by conventional sequencing approaches. This provides a more complete view of disease, supporting better target identification, patient stratification, and clinical decision-making.
What it enables
Improved Clinical Success
More precise biomarkers to optimise patient selection and trial outcomes.
Novel Target Discovery
Identification of disease specific RNA isoforms for next-generation therapies.
Next-Generation Diagnostics
Enhanced accuracy through isoform level resolution.
Why it matters
Incomplete biological insight is a major driver of drug failure. Level-Up™ provides a more complete and actionable view of RNA, helping partners reduce risk, accelerate development, and improve outcomes across the pipeline.
The RNA platform powering the next wave of precision medicine
Wobble Genomics’ Level-Up™ platform enables a deeper and more actionable understanding of RNA biology.
Designed for pharmaceutical and diagnostics partners, it captures full-length RNA transcripts to reveal critical variation missed by conventional sequencing approaches. This provides a more complete view of disease, supporting better target identification, patient stratification, and clinical decision-making.
What it enables
Improved Clinical Success
More precise biomarkers to optimise patient selection and trial outcomes.
Novel Target Discovery
Identification of disease specific RNA isoforms for next-generation therapies.
Next-Generation Diagnostics
Enhanced accuracy through isoform level resolution.
Why it matters
Incomplete biological insight is a major driver of drug failure. Level-Up™ provides a more complete and actionable view of RNA, helping partners reduce risk, accelerate development, and improve outcomes across the pipeline.
Turning complex RNA data into actionable insight
Wobble Genomics’ TAMA™ is a next-generation bioinformatics platform designed to unlock the full value of long-read RNA sequencing.
By combining advanced algorithms with AI-driven analytics, TAMA transforms complex transcriptomic data into clear, actionable insights for diagnostics and pharmaceutical development.
What it enables
Accurate Transcript Identification
Precise detection of genes, isoforms, and fusion events with high sensitivity.
AI-Driven Insight
Identification and prioritisation of clinically relevant patterns and transcriptomic changes.
Integrated Analysis
Seamless integration with Level-Up™ and ATLUS Targeting to combine full-length resolution, targeted detection, and transcriptome-wide context.
Why it matters
The value of sequencing lies in interpretation.
TAMA™ converts complex RNA data into meaningful insight, enabling better decisions in biomarker discovery, patient stratification, and drug development.
Turning complex RNA data into actionable insight
Wobble Genomics’ TAMA™ is a next-generation bioinformatics platform designed to unlock the full value of long-read RNA sequencing.
By combining advanced algorithms with AI-driven analytics, TAMA transforms complex transcriptomic data into clear, actionable insights for diagnostics and pharmaceutical development.
What it enables
Accurate Transcript Identification
Precise detection of genes, isoforms, and fusion events with high sensitivity.
AI-Driven Insight
Identification and prioritisation of clinically relevant patterns and transcriptomic changes.
Integrated Analysis
Seamless integration with Level-Up™ and ATLUS Targeting to combine full-length resolution, targeted detection, and transcriptome-wide context.
Why it matters
The value of sequencing lies in interpretation.
TAMA™ converts complex RNA data into meaningful insight, enabling better decisions in biomarker discovery, patient stratification, and drug development.
